Assenagon Asset Management S.A. Iveric Bio, Inc. Transaction History

Assenagon Asset Management S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$12.15 - $16.83 $521,453 - $722,309	-42,918 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$13.83 - $18.78 $3.67 Million - $4.99 Million	-265,495 Reduced 86.08%	42,918 $718,000
Q3 2021 Oct 19, 2021	SELL	$7.07 - $17.5 $10.4 Million - $25.8 Million	-1,475,948 Reduced 82.72%	308,413 $5.01 Million
Q2 2021 Jul 15, 2021	BUY	$5.69 - $7.17 $10.2 Million - $12.8 Million	1,784,361 New	1,784,361 $11.3 Million
Q4 2019 Jan 17, 2020	SELL	$0.93 - $8.58 $200,913 - $1.85 Million	-216,036 Closed	0 $0
Q3 2019 Oct 16, 2019	SELL	$1.09 - $1.29 $19,063 - $22,560	-17,489 Reduced 7.49%	216,036 $242,000
Q2 2019 Aug 12, 2019	BUY	$1.21 - $1.48 $282,565 - $345,617	233,525 New	233,525 $304,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.